Recent knowledge on molecular components of Lewy bodies discloses future therapeutic strategies in Parkinson's disease. | Curr Drug Targets CNS Neurol Disord;2(3): 149-52, 2003 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Recent knowledge on molecular components of Lewy bodies discloses future therapeutic strategies in Parkinson's disease.

Fornai, F; Lenzi, P; Gesi, M; Ferrucci, M; Lazzeri, G; Natale, G; Ruggieri, S; Paparelli, A.

Affiliation

Fornai F; Department of Human Morphology and Applied Biology, University of Pisa, Pisa, Italy. f.fornai@med.unipi.it

Curr Drug Targets CNS Neurol Disord ; 2(3): 149-52, 2003 Jun.

Article in En | MEDLINE | ID: mdl-12769795

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ubiquitins / Lewy Bodies / Neurodegenerative Diseases / Drug Evaluation, Preclinical Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Drug Targets CNS Neurol Disord Journal subject: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ubiquitins / Lewy Bodies / Neurodegenerative Diseases / Drug Evaluation, Preclinical Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Drug Targets CNS Neurol Disord Journal subject: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country: